Russia Coronavirus Vaccination
Search results: 46 photos
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4985x3332px, 8.8Mb
- Job-ID: 16de5c10cd31aafe
Patients wait in a corridor to get an injection with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4953x3244px, 12.2Mb
- Job-ID: c267830b178c1693
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5499x3629px, 11.1Mb
- Job-ID: e6c76acd6d8e44a7
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 2272x2861px, 3.2Mb
- Job-ID: 9dfac08d585231e5
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4729x3223px, 7.4Mb
- Job-ID: f0e442d4a9e33b5b
The view shows an ampoule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") vaccine against coronavirus infection at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5483x3561px, 11Mb
- Job-ID: 7dbd95b3335fb9cc
Boxes with the two-component Gam-COVID-VAK (trademark "Sputnik V") vaccine against coronavirus infection are pictured at Murmansk regional center of specialized types of medical care, in Murmansk, Russia. Russia launched a mass coronavirus vaccination campaign on Monday, January 18.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Murmansk, Russia
- Event date: 18.01.2021
- Date published: 18.01.2021
- Author: Pavel Lvov
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3312x2241px, 4.6Mb
- Job-ID: 68209123457a8a4b
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5041x3361px, 9.7Mb
- Job-ID: 99721865ea3069
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 10.1Mb
- Job-ID: 9e338c2193634bd1
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 10.6Mb
- Job-ID: 69d0f1d267c416b7
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 10.5Mb
- Job-ID: 5eb46c6535129309
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5052x3368px, 9.2Mb
- Job-ID: 646d490212528bff
A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 10.3Mb
- Job-ID: 13266f39449a3453
People queue for an injection of the coronavirus vaccine Gam-COVID-VAK (trademark "Sputnik V") at a vaccination point in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4523x2956px, 6.3Mb
- Job-ID: 36b6a5ff7caed0e6
An elderly man wearing a protective face mask waits for an injection of the coronavirus vaccine Gam-COVID-VAK (trademark "Sputnik V") at a vaccination point in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 6.1Mb
- Job-ID: c06abd98d231b757
People queue for an injection of the coronavirus vaccine Gam-COVID-VAK (trademark "Sputnik V") at a vaccination point in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 7Mb
- Job-ID: 7d0c0c4290f515fd
A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4341x2894px, 5.7Mb
- Job-ID: c68d55e3cf5ed5a8
People queue for an injection of the coronavirus vaccine Gam-COVID-VAK (trademark "Sputnik V") at a vaccination point in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 6.6Mb
- Job-ID: 3c91754e66c9d4cd
A medical worker holds vaccination certificates for patients vaccinated with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5026x3547px, 7.1Mb
- Job-ID: 59a35f02d872fa07
A medical worker fills a syringe with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3712x5568px, 5.5Mb
- Job-ID: 94f85765ed57ecc6
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5130x3452px, 7.8Mb
- Job-ID: fafdbcf65d974dca
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine to a patient, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 9.1Mb
- Job-ID: b4c6acb789143c22
A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5078x3278px, 8.3Mb
- Job-ID: 326b43cb0519486
A medical worker takes the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine out of the refrigerator, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5182x3569px, 8.7Mb
- Job-ID: 4dc91d48d97608b5
A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 8.5Mb
- Job-ID: 2db00e6f101a9492
An elderly man fills in a form before vaccination with Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 9.2Mb
- Job-ID: 351f14186fc07d73
A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 2409x3148px, 3.4Mb
- Job-ID: 6379681d45bf4f39
A medical worker examines an elderly woman before vaccination with Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
- Package: Russia Coronavirus Vaccination
- Categories: Social Issues, Health
- Location: Moscow, Russia
- Event date: 14.01.2021
- Date published: 14.01.2021
- Author: Alexey Kudenko
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 7.3Mb
- Job-ID: 78edbddfd93c29f0
People queue to get injects the Gam-COVID-VAK (trademark "Sputnik V"), in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
An elderly man holds a vaccination certificate after being injected with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
An elderly man holds a vaccination certificate after being injected with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
The view shows ampoules of "component 1" and "component 2" of the two-component vector vaccine the Sputnik-V against coronavirus infection, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
The view shows packs of "component 1" and "component 2" of the two-component vector vaccine the Sputnik-V against coronavirus infection, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker fills a syringe with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
The view shows an ampoule "component 1" of the two-component vector vaccine the Sputnik-V against coronavirus infection, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker takes the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine out of the refrigerator, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker prepares a vaccination certificate for a patient after injecting him with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
The view shows an ampoule "component 1" of the two-component vector vaccine the Sputnik-V against coronavirus infection, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker injects the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker fills a syringe with the Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A medical worker measures blood pressure of a man before vaccination with Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.
A man registers before vaccination with Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.v
